Z, Z., D, N., W, Q., H, F., L, J., & W, Z. (2026). Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway. Drug design, development and therapy, 20, 599539. https://doi.org/10.2147/DDDT.S599539
Chicago Style (17th ed.) CitationZ, Zhang, Niu D, Qiu W, Feng H, Jia L, and Zhou W. "Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway." Drug Design, Development and Therapy 20 (2026): 599539. https://doi.org/10.2147/DDDT.S599539.
MLA (9th ed.) CitationZ, Zhang, et al. "Semaglutide Inhibits Osteoblast Ferroptosis Induced by Diabetic Periodontitis via Modulating the Wnt5a/Ror2/p38 MAPK Signaling Pathway." Drug Design, Development and Therapy, vol. 20, 2026, p. 599539, https://doi.org/10.2147/DDDT.S599539.